- Home
- NPWR vs TLSA Comparison
NPWR vs TLSA Comparison
Compare NPWR & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPWR
- TLSA
- Stock Information
- Founded
- NPWR 2010
- TLSA 2013
- Country
- NPWR United States
- TLSA United Kingdom
- Employees
- NPWR N/A
- TLSA N/A
- Industry
- NPWR Industrial Machinery/Components
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- NPWR Energy
- TLSA Health Care
- Exchange
- NPWR Nasdaq
- TLSA Nasdaq
- Market Cap
- NPWR 171.3M
- TLSA 187.0M
- IPO Year
- NPWR N/A
- TLSA 2000
- Fundamental
- Price
- NPWR $2.26
- TLSA $1.66
- Analyst Decision
- NPWR Buy
- TLSA
- Analyst Count
- NPWR 2
- TLSA 0
- Target Price
- NPWR $4.00
- TLSA N/A
- AVG Volume (30 Days)
- NPWR 764.6K
- TLSA 325.5K
- Earning Date
- NPWR 11-10-2025
- TLSA 05-06-2025
- Dividend Yield
- NPWR N/A
- TLSA N/A
- EPS Growth
- NPWR N/A
- TLSA N/A
- EPS
- NPWR N/A
- TLSA N/A
- Revenue
- NPWR $12,000.00
- TLSA N/A
- Revenue This Year
- NPWR $172.00
- TLSA N/A
- Revenue Next Year
- NPWR $100.00
- TLSA N/A
- P/E Ratio
- NPWR N/A
- TLSA N/A
- Revenue Growth
- NPWR N/A
- TLSA N/A
- 52 Week Low
- NPWR $1.48
- TLSA $0.63
- 52 Week High
- NPWR $14.28
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- NPWR 44.85
- TLSA 43.10
- Support Level
- NPWR $2.07
- TLSA $1.63
- Resistance Level
- NPWR $2.22
- TLSA $1.88
- Average True Range (ATR)
- NPWR 0.13
- TLSA 0.15
- MACD
- NPWR 0.00
- TLSA -0.01
- Stochastic Oscillator
- NPWR 31.90
- TLSA 38.46
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.